ICON (ICLR) return on equity (ROE)

Return on equity · fiscal 2025
2.5%

ICON (ICLR) earned a return on equity of 2.5% in fiscal 2025 (the year ended December 31, 2025). That is 5.3 percentage points lower than the 7.8% of fiscal 2024. Figures as of 17 Nov 2026, 20:48 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
2.5%
Change on fiscal 2024
−5.3 pts
Highest on record
31.4%fiscal 2015
Lowest on record
1.9%fiscal 2021
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

ICON return on equity (ROE), in more detail

Across the 18 fiscal years on record (2008–2025), the highest was 31.4% in fiscal 2015 and the lowest 1.9% in fiscal 2021. The fiscal 2025 figure is higher than in 6% of the 17 earlier fiscal years on record, whose median is 16.5%.

History · 18 fiscal years

Return on equity by fiscal year

ICON return on equity (ROE), year by year

ICON (ICLR) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
20252.5% 5.3 pts down
20247.8% 1.8 pts up
20236.0% 0.1 pts up
20225.9% 4.0 pts up
20211.9% 16.1 pts down
202018.0% 5.2 pts down
201923.1% 0.7 pts down
201823.8% 0.2 pts up
201723.6% 4.1 pts down
201627.7% 3.7 pts down
201531.4% 13.2 pts up
201418.2% 6.9 pts up
201311.3% 3.9 pts up
20127.3% 4.0 pts up
20113.4% 9.6 pts down
201013.0% 3.5 pts down
200916.5% 0.6 pts down
200817.1%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of ICON and comparable companies
CompanyReturn on equityFiscal year
Neurocrine Biosciences NBIX14.7%2025
Ascendis Pharma ASND-221.5%2022
ICON ICLR2.5%2025
Jazz Pharmaceuticals JAZZ-8.2%2025
Solventum SOLV30.8%2025
BridgeBio Pharma BBIO-872.9%2020

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ICLR

ICON, figure by figure

ICON (ICLR) overview: price, valuation and scorecardAll health care companies by market value

ICON return on equity (ROE): questions and answers

What is ICON's return on equity?

ICON (ICLR) earned a return on equity of 2.5% in fiscal 2025 (the year ended December 31, 2025). That is 5.3 percentage points lower than the 7.8% of fiscal 2024.

Is ICON's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 6% of the 17 earlier fiscal years on record, whose median is 16.5%.

What are the highest and lowest return on equity figures on record for ICON?

Across the 18 fiscal years on record (2008–2025), the highest was 31.4% in fiscal 2015 and the lowest 1.9% in fiscal 2021.

How is ICON's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ICON (ICLR) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/ICLR/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.